Literature DB >> 24547957

Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections.

D A van Kessel1, T W Hoffman, H van Velzen-Blad, P Zanen, G T Rijkers, J C Grutters.   

Abstract

Mannose-binding lectin (MBL)-deficiency is associated with an increased susceptibility to pneumococcal infections and other forms of disease. Pneumococcal vaccination is recommended in MBL-deficient patients with recurrent respiratory tract infections (RRTI). The response to pneumococcal vaccination in MBL-deficient individuals has not yet been studied in detail. An impaired response to pneumococcal polysaccharides in MBL-deficient patients might explain the association between MBL deficiency and pneumococcal infections. This study investigates the antibody response to pneumococcal vaccination in MBL-deficient adult patients with RRTI. Furthermore, we investigated whether there was a difference in clinical presentation between MBL-deficient and -sufficient patients with RRTI. Eighteen MBL-deficient and 63 MBL-sufficient adult patients with RRTI were all vaccinated with the 23-valent pneumococcal polysaccharide vaccine and antibodies to 14 pneumococcal serotypes were measured on a Luminex platform. There were no differences observed in the response to pneumococcal vaccination between MBL-sufficient and -deficient patients. Forty-three MBL-sufficient patients could be classified as responders to pneumococcal vaccination and 20 as low responders, compared to 15 responders and three low responders in the MBL-deficient patients. We found no clear difference in clinical, radiological, lung function and medication parameters between MBL-sufficient and -deficient patients. In conclusion, our study suggests that MBL-deficient adults with RRTI have a response to a pneumococcal capsular polysaccharide vaccine comparable with MBL-sufficient patients. Moreover, we did not find a clear clinical role of MBL deficiency in adults with RRTI. As MBL deficiency is associated with an increased susceptibility to pneumococcal infections, pneumococcal vaccination might be protective in MBL-deficient patients with RRTI.
© 2014 British Society for Immunology.

Entities:  

Keywords:  antibodies; immunodeficiency diseases; mannose binding lectin; pneumococcal vaccination

Mesh:

Substances:

Year:  2014        PMID: 24547957      PMCID: PMC4089177          DOI: 10.1111/cei.12299

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Authors:  O Neth; D L Jack; A W Dodds; H Holzel; N J Klein; M W Turner
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population.

Authors:  R M Minchinton; M M Dean; T R Clark; S Heatley; C G Mullighan
Journal:  Scand J Immunol       Date:  2002-12       Impact factor: 3.487

4.  Primary antibody deficiency and diagnostic delay.

Authors:  J Blore; M R Haeney
Journal:  BMJ       Date:  1989-02-25

5.  Corticosteroid effect on immunoglobulins.

Authors:  G A Settipane; R K Pudupakkam; J H McGowan
Journal:  J Allergy Clin Immunol       Date:  1978-09       Impact factor: 10.793

6.  The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels.

Authors:  W C Posey; H S Nelson; B Branch; D S Pearlman
Journal:  J Allergy Clin Immunol       Date:  1978-12       Impact factor: 10.793

7.  Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone.

Authors:  W T Butler; R D Rossen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

8.  Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.

Authors:  Lisa A Jackson; Alejandra Gurtman; Martin van Cleeff; Kathrin U Jansen; Deepthi Jayawardene; Carmel Devlin; Daniel A Scott; Emilio A Emini; William C Gruber; Beate Schmoele-Thoma
Journal:  Vaccine       Date:  2013-05-18       Impact factor: 3.641

Review 9.  Mannan-binding lectin--a soluble pattern recognition molecule.

Authors:  Mihaela Gadjeva; Kazue Takahashi; Steffen Thiel
Journal:  Mol Immunol       Date:  2004-06       Impact factor: 4.407

Review 10.  Human Mannose-binding Lectin in Immunity: Friend, Foe, or Both?

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

View more
  7 in total

1.  Mannose-binding lectin and ficolin-2 do not influence humoral immune response to hepatitis B vaccine.

Authors:  Michael Osthoff; Elizabeth Irungu; Kenneth Ngure; Nelly Mugo; Katherine K Thomas; Jared M Baeten; Damon P Eisen
Journal:  Vaccine       Date:  2014-07-10       Impact factor: 3.641

2.  Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study.

Authors:  Jyotshna Mandal; Bijaya Malla; Rudi Steffensen; Luigi Costa; Adrian Egli; Marten Trendelenburg; Francesco Blasi; Kostantinos Kostikas; Tobias Welte; Antoni Torres; Renaud Louis; Wim Boersma; Branislava Milenkovic; Joachim Aerts; Gernot G U Rohde; Alicia Lacoma; Katharina Rentsch; Michael Roth; Michael Tamm; Daiana Stolz
Journal:  Respir Res       Date:  2015-12-18

3.  Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract Infections.

Authors:  Diana A van Kessel; Thijs W Hoffman; Heleen van Velzen-Blad; Pieter Zanen; Jan C Grutters; Ger T Rijkers
Journal:  EBioMedicine       Date:  2017-03-21       Impact factor: 8.143

4.  Clinical and laboratory associations of mannose-binding lectin in 219 adults with IgG subclass deficiency.

Authors:  James C Barton; Jackson C Barton; Luigi F Bertoli
Journal:  BMC Immunol       Date:  2019-05-22       Impact factor: 3.615

5.  Pneumococcal vaccination responses in adults with subnormal IgG subclass concentrations.

Authors:  Antony R Parker; Markus Skold; Stephen Harding; J Clayborn Barton; Luigi F Bertoli; James C Barton
Journal:  BMC Immunol       Date:  2019-08-20       Impact factor: 3.615

6.  Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.

Authors:  T W Hoffman; B Meek; G T Rijkers; D A van Kessel
Journal:  Transpl Immunol       Date:  2022-04-04       Impact factor: 2.032

7.  Immunogenicity of a 5-dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation.

Authors:  Hannah M Garcia Garrido; Sabine Haggenburg; Marieke C E Schoordijk; Ellen Meijer; Michael W T Tanck; Mette D Hazenberg; Caroline E Rutten; Godelieve J de Bree; Erfan Nur; Bob Meek; Martin P Grobusch; Abraham Goorhuis
Journal:  Am J Hematol       Date:  2022-02-17       Impact factor: 13.265

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.